DENVER, March 08, 2017 (GLOBE NEWSWIRE) -- Global CBD cannabis innovator Elixinol has announced the launch of Respira, a versatile, full-spectrum cannabidiol (CBD) tincture line.
Photos accompanying this announcement are available at
Elixinol has developed Respira with all natural ingredients, making Respira a multi-purpose CBD product suitable for consumption orally, topically, or by vape.
As CBD gains in popularity as a cannabis product without psychoactive properties, consumers are seeking ways to incorporate CBD into their daily lives including topical, digestive and vape oil.
“Respira is our most versatile tincture to date, the customer has complete control over the delivery mechanisms,” said Chris Husong, Director of Marketing and Sales of Elixinol. “As cannabis and CBD customers become more educated, we will continue to develop convenient, high-quality products designed for how our customers are using CBD today.”
Each 10 mg serving size of Respira delivers high concentrations of either 300 mg or 600 mg of CBD oil. Respira is sold in two refreshing flavors, grape-mint and natural.
“I use Respira to ease anxiety, pain and headaches associated with my chronic traumatic encephalopathy (CTE). I can use this as a vape oil in my vape pen when I’m on the go,” said CBD advocate and New York Giants Super Bowl champion Leonard Marshall. “This is a product formulated for busy people like me, and it allows me to be my best me.”
Colorado-based Elixinol, founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and manufacturing high-quality hemp, Elixinol also conducts rigorous laboratory testing and quality control. A global leader in hemp distribution, Elixinol distributes CBD products globally in the United States, Japan, Puerto Rico and the UK. More information is available at Elixinol.com.
Media Contact: Chris Husong Elixinol 844-804-3504 ext 420 email@example.com